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A clear relationship exists between visceral obesity
and type 2 diabetes, whereas subcutaneous obesity
is comparatively benign. Here, we show that adipo-
cyte-specific deletion of the coregulatory protein
PRDM16 caused minimal effects on classical brown
fat but markedly inhibited beige adipocyte function
in subcutaneous fat following cold exposure or b3-
agonist treatment. These animals developed obesity
on a high-fat diet, with severe insulin resistance and
hepatic steatosis. They also showed altered fat
distribution with markedly increased subcutaneous
adiposity. Subcutaneous adipose tissue in mutant
mice acquired many key properties of visceral fat,
including decreased thermogenic and increased
inflammatory gene expression and increasedmacro-
phage accumulation. Transplantation of subcutane-
ous fat into mice with diet-induced obesity showed
a loss ofmetabolic benefit when tissueswere derived
from PRDM16 mutant animals. These findings indi-
cate that PRDM16 and beige adipocytes are required
for the ‘‘browning’’ of white fat and the healthful ef-
fects of subcutaneous adipose tissue.
INTRODUCTION
Obesity has become a global epidemic, contributing to in-
creases in the prevalence of type 2 diabetes, hypertension, car-
diovascular disease, and certain cancers. Generally, two broad
categories of obesity are recognized: visceral (VISC) and subcu-304 Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc.taneous (SubQ). The location where fat is deposited appears
to have a great influence on the likelihood of an individual
developing many of the sequelae of obesity (Gesta et al.,
2007). Importantly, VISC adiposity is strongly associated with
increased mortality, even in individuals with a normal body
mass index (Pischon et al., 2008). SubQ adiposity, however, ap-
pears to be comparatively benign (Manolopoulos et al., 2010).
The association between regional fat deposition and adverse
health complications was first noted with pioneering clinical
descriptions in the 1950s (Vague, 1956). It has also been recog-
nized for centuries that men have a greater propensity for depo-
sition of VISC fat, while premenopausal women have a greater
tendency to accumulate fat in SubQ stores, though substantial
variation exists in both sexes (Vague, 1947).
The relationship between site of adipose tissue accumulation
and metabolic disease has been shown in several animal
models. Transgenic mice overexpressing 11-bHSD-1 in adipose
tissue develop VISC obesity along with insulin resistance, dia-
betes, and hyperlipidemia (Masuzaki et al., 2001). Conversely,
transgenic mice overexpressing adiponectin or mitoNEET in
adipose tissue develop remarkable SubQ obesity, but remain
metabolically healthy (Kim et al., 2007; Kusminski et al., 2012).
The functional importance of these adipose depots has been
directly demonstrated in studies showing metabolic benefit
by transplantation of SubQ fat or surgical removal of VISC fat
(Gabriely et al., 2002; Tran et al., 2008).
These divergent metabolic effects of different adipose depots
have raised interest in the unique properties of VISC and
SubQ fat. VISC fat is notable for having a substantial degree of
inflammation when obesity is present. Originally recognized as
the secretion of TNFa and other inflammatory cytokines from
fat tissue of obese animals (Hotamisligil et al., 1993), it is now
known that there is a broad increase in a variety of immune cells
in obese fat (Weisberg et al., 2003; Xu et al., 2003). On the other
hand, SubQ fat is notable because it can easily ‘‘brown’’ when
animals are stimulated with cold, b-adrenergic agonists, or
other hormone-like stimuli (Vitali et al., 2012; Wu et al., 2013).
This browning includes the induction of UCP1 mRNA and
protein, and expression of a gene program that gives rise to
uncoupled respiration and heat production. Some stimuli, such
as the genetic ablation of RALDH1, cause considerable brown-
ing of the VISC depots in mice (Kiefer et al., 2012), but this
phenomenon is much less common than the browning of
SubQ depots.
It is now recognized that there are at least two distinct types
of brown fat cells. Classical brown adipose tissue (BAT), epito-
mized by the interscapular depot in rodents, arises from a
Myf5+, muscle-like cell lineage. PRDM16, a transcriptional
regulatory protein, appears to control this muscle-brown fat
decision between days 9–12 of gestation in mice (Lepper and
Fan, 2010; Seale et al., 2008). The postnatal role of PRDM16 in
classical BAT has not been studied. In contrast, the UCP1+ cells
that emerge in white fat depots under certain stimuli, termed
beige or brite cells, do not come from aMyf5+ lineage. However,
PRDM16 also appears to be involved in the development and
function of beige cells (Ohno et al., 2012; Seale et al., 2011).
Hence, beige and classical brown fat cells both express
PRDM16 and UCP1 but they are quite distinct cell types. Beige
fat cells have now been cloned and characterized (Wu et al.,
2012). Importantly, the depots of ‘‘brown fat’’ visualized in hu-
mans share more molecular properties with rodent beige fat
than with classical BAT (Lidell et al., 2013; Sharp et al., 2012;
Wu et al., 2012). The kite-like structure in the interscapular region
of human infants, however, seems to have characteristics of
rodent classical BAT, and some classical brown fat cells may
be retained in adult humans (Cypess et al., 2013; Jespersen
et al., 2013; Lidell et al., 2013).
Analysis of the relative physiological importance of the
classical BAT versus the browning of white fat has been very
difficult because many important browning agents, such as
cold and b-adrenergic compounds, affect both types of brown
fat cells. Similarly, while ablation of UCP1+ cells or mutation of
Ucp1 illustrate the overall importance of brown fat in preventing
obesity and diabetes in animals, the individual contributions
of the two types of brown fat cells has been impossible to
determine (Feldmann et al., 2009; Lowell et al., 1993). Agents
that affect browning of white fat selectively, including transgenic
expression of PRDM16, have caused metabolic benefit, sug-
gesting that browning of white tissues could be important (Seale
et al., 2011). On the other hand, it has been argued that there are
insufficient beige cells to affect whole-body physiology under
ambient conditions (Nedergaard and Cannon, 2013).
We have now created an adipocyte-selective mutation in the
Prdm16 gene that ablates the thermogenic program of beige
fat cells, while leaving the classical BAT functionally intact.
Mice lacking beige fat function develop obesity and insulin resis-
tance when exposed to high-fat diet (HFD) and also develop
hepatic steatosis. In addition, there is a striking change in the
SubQ fat, which takes on many of the morphological and molec-
ular characteristics of VISC fat. These data demonstrate that
PRDM16 and beige fat cells are major regulators of systemicphysiology. Moreover, PRDM16 determines some of the key
functional differences between SubQ and VISC fat.
RESULTS
PRDM16 Is Enriched in SubQ Adipose Tissues and
Required for Thermogenic Gene Expression
PRDM16 is involved in the development and function of classical
brown and beige adipocytes. To determine how PRDM16 might
be involved in the function of different adipose tissues that are
considered ‘‘white,’’ we measured mRNA levels in multiple
SubQ and VISC fat depots and compared these to the classical
interscapular brown fat. Prdm16 was significantly elevated in
two SubQ depots (inguinal and axillary) relative to the very low
levels of expression in two VISC depots (epididymal and mesen-
teric). As expected, the highest levels of expression were seen
in interscapular BAT (Figure 1A). This depot enrichment was
maintained in primary adipocytes differentiated in vitro from
the inguinal SubQ or epididymal VISC stromal vascular fraction
(SVF) (Figure 1B). Expression of Ucp1, the prototypical thermo-
genic gene, was also enriched across SubQ depots, consistent
with the presence of beige adipocytes in these pads (Figures
S1A and S1B available online). These data suggested that
PRDM16 could play a role in multiple SubQ depots.
We generated a conditional Prdm16 allele (Prdm16lox/lox) by
engineering loxP sites flanking exon 9, which we have shown
to be required for mediating the effects of PRDM16 on thermo-
genic gene expression (Seale et al., 2008) (Figure S1C). We
initially crossed Prdm16lox/lox mice to Zp3-cre mice to generate
a germline deletion. As expected, these animals had craniofacial
defects and died within 24 hr of birth, confirming that this muta-
tion created a null allele of Prdm16 (Bjork et al., 2010).
We next crossed Prdm16lox/lox and Adiponectin-cre mice
(Eguchi et al., 2011) to generate mice with an adipocyte-specific
knockout (KO) of Prdm16 (Adipo-PRDM16 KO). This promoter
expresses cre recombinase after the early developmental time
point when the classical brown fat/muscle fate decision
has been established (Lepper and Fan, 2010). We performed
metabolic characterization of Adiponectin-cre mice and
confirmed that the Cre recombinase is not likely to contribute
to the KO phenotype (Figure S1D). Analysis of mRNA expression
from multiple tissues confirmed that the deletion was specific to
white and brown adipose tissues (Figure 1C). Notably, PRDM16
mRNA levels in epididymal fat trended downward in KO mice,
though expression in this depot was at the margin of detection.
The trend toward decreased Prdm16 in the kidney of KO mice
may reflect expression in adipose tissue surrounding this organ.
Western blotting of nuclear extracts showed a marked reduction
of PRDM16 protein in both classical BAT and inguinal SubQ
adipose tissue from KO mice (Figure 1D). PRDM16 protein was
too low to detect in the VISC depots.
PRDM16 deletion in the classical BAT resulted in a relatively
normal pattern of gene expression (Figure 1E). The SubQ
adipose tissue of Adipo-PRDM16 KO mice, however, showed
reduced expression of a broad panel of thermogenic (Dio2,
Pgc1a, and Ucp1), brown adipose identity (Cidea, Otop1, and
PPARa), and mitochondrial electron transport genes (Coxiii,
Cox5b, and Cox8b) (Figure 1F). There was no alteration in theCell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc. 305
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Figure 1. PRDM16 Deletion in Adipocytes Results in Altered Subcutaneous Adipose Tissue Gene Expression
(A and B) qPCR analysis of Prdm16mRNA frommultiple adipose tissues from 8- to 10-week-old, male wild-type mice (n = 9), normalized to mRNA expression in
BAT (A) or from in vitro differentiated primary adipocytes, normalized to mRNA expression in inguinal cells (n = 3) (B).
(C) qPCR analysis of Prdm16 mRNA from multiple tissues from 6- to 8-week-old male Adipo-PRDM16 KO mice (n = 4) and controls (n = 4).
(D) PRDM16 protein in nuclear extracts from BAT or inguinal SubQ adipose tissue from Adipo-PRDM16 KO and controls. PPARg and TBP protein are shown as
controls.
(E and F) Normalized gene expression of thermogenic, brown adipose, and mitochondrial genes in BAT (E) and SubQ adipose tissue (F) from Adipo-PRDM16 KO
and control mice at RT. Mice were males, 6–8 weeks old, n = 5 per group.
Data are presented as mean ± SEM. *p < 0.05. #, p = 0.053 for kidney and 0.079 for epididymal fat. See also Figure S1.expression of Pparg, which is a general marker of adipose
differentiation. Ucp1mRNA was reduced by 90% in the inguinal
SubQ depot. This did not reach statistical significance (p = 0.14)
due to the large variance in Ucp1 mRNA levels in control mice.
Adipo-PRDM16 KO mice also had decreased expression of a
few of these genes in VISC adipose tissue, compared to con-
trols, though the absolute expression level of these genes was
very low (Figure S1E).
Since SubQ adipose tissues are particularly prone to inducing
a thermogenic gene program (‘‘browning’’), we examined the
effects of two potent stimuli: cold exposure and treatment with
a b-adrenergic agonist. In interscapular BAT, the thermogenic
program was induced similarly in both control and Adipo-
PRDM16 KO animals following cold exposure or CL 316,243
(hereafter referred to as CL) treatment. There were some small
but statistically significant differences in the induction of several
genes with cold and CL treatment (Figures 2A and 2B). In
contrast, the very robust increase in the entire panel of thermo-
genic gene expression seen in control inguinal adipose tissues
(cold: 74-fold induction of Ucp1, CL: > 400-fold induction of
Ucp1) was almost completely blocked in KO animals (Figures
2C and 2D). A similar pattern showing selective effects in
SubQ adipose tissue was seen with prolonged cold exposure306 Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc.for 6 days (Figures S2A and S2B). Ucp1 showed blunted induc-
tion in VISC adipose tissue of the Adipo-PRDM16 KO mice
following CL treatment, though the levels of thermogenic genes
were overall very low in this depot (Figure S2C).
The morphology and UCP1 content of these adipose depots
was also examined in control and Adipo-PRDM16 KO mice.
No differences in UCP1 were seen in the BAT between mice
of either genotype, with or without cold exposure (Figure 2E).
The SubQ adipose tissue from Adipo-PRDM16 KO mice, how-
ever, contained larger adipocytes and fewer small, multilocular
UCP1+ adipocytes (Figure 2E). Moreover, cold exposure re-
sulted in the emergence of numerous small, multilocular
UCP1+ adipocytes in controls, while KO mice showed no
change in appearance relative to RT (Figure 2E). Of note,
Adipo-PRDM16 KO mice showed no difference in core tem-
perature following 6 hr (Figure S2D) or 96 hr at 4C (36.04C ±
0.19 in KOs versus 35.78C ± 0.26 in controls, p = 0.44). This
further indicates that these mice have little apparent defect in
the function of BAT since ablation of classical BAT or UCP1 is
associated with severe cold intolerance (Enerba¨ck et al., 1997;
Lowell et al., 1993).
We next asked whether these changes in the thermogenic
program of SubQ adipose tissue were cell autonomous. SubQ
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Figure 2. PRDM16 Regulates Beige Adipose Thermogenic Gene Expression
(A–D) Normalized thermogenic gene expression in BAT (A and B) and SubQ adipose tissue (C and D) from Adipo-PRDM16 KO and control mice at RT and
following 48 hr at 4C (A and C) or following five daily injections of 1 mg/kg CL (B and D). Cold exposure was done with male 6- to 8-week-old mice, n = 5–6 per
group. CL treatment was done with female 6- to 8-week-old mice, n = 5–6 per group. Data are presented as mean ± SEM. *p < 0.05 KO versus control cold
exposed or CL treated. #, p < 0.05 KO versus control room temperature or untreated.
(E) Representative images from UCP1 immunohistochemistry on sections of interscapular BAT or inguinal SubQ adipose tissue from Adipo-PRDM16 KO and
control mice at RT or following 48 hr at 4C. Images are shown at 103 magnification. Scale bar, 100 mm.
See also Figure S2.
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Figure 3. Altered Subcutaneous Adipose
Tissue and Whole-Body O2 Consumption in
Adipo-PRDM16 KO Mice
(A and B) O2 consumption in brown (A) and SubQ
adipose tissue (B) from control and Adipo-PRDM16
KO mice. Tissues from untreated animals and ani-
mals treated with 5 daily injections of 1 mg/kg CL
were analyzed. CL treatment was done with female
6- to 8-week-old mice, n = 5–6 per group.
(C) Total and uncoupled respiration in primary SubQ
adipocytes from control and Adipo-PRDM16 KO
mice. n = 6 per group.
(D) O2 consumption in 8- to 10-week-old Adipo-
PRDM16KOand controlmalemice, n = 8 per group.
Data were recorded at baseline and for 6 hr
following daily injection of 0.1 mg/kg CL.
Data are presented as mean ± SEM. *p < 0.05. **p <
0.001. See also Figure S3.adipocytes from KO mice differentiated in vitro also showed a
significant reduction in the expression of most thermogenic
(81% reduction in Ucp1), brown fat identity (97% reduction in
Cidea), and mitochondrial genes (80% reduction in Cox8b),
strongly suggesting a cell-autonomous role for PRDM16 in
browning (Figure S2E). Cells from Adipo-PRDM16 KO mice
also showed a blunted response to stimuli that induce browning,
such as isoproterenol and FGF21 (Figures S2F ad S2G) (Fisher
et al., 2012; Wu et al., 2013).
PRDM16 Regulates Adipose Tissue and Whole-Body
Energy Expenditure
Given the preferential effect of this PRDM16 deletion on
thermogenic gene expression in beige adipocytes, we
assessed the physiological effect of this ablation, using O2
consumption as a readout. SubQ and BAT pads were removed
from mice and O2 consumption was measured. These assays
were performed both in untreated animals and after 5 days
of CL treatment. Importantly, O2 consumption in interscapular
BAT was unchanged between KOs and controls in both basal
and stimulated states (Figure 3A). In contrast, O2 consumption
in SubQ adipose tissue from Adipo-PRDM16 KO mice was
significantly reduced, both at baseline (36% reduced) and
following stimulation with CL (49% reduced) (Figure 3B). O2
consumption in VISC adipose tissue was below the limit of
detection in most animals. Assays in primary SubQ adipocytes
showed a significant reduction in both total (33% reduced)
and uncoupled (51% reduced) respiration in KO cells
compared to controls (Figure 3C). Taken together, these re-
sults indicate that adipose-selective deletion of PRDM16 re-
sults in a large defect in a broad program of thermogenesis
in SubQ adipose tissue, while classical BAT is relatively
unaffected.308 Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc.This selective ablation of beige cell ther-
mogenic function offered a unique oppor-
tunity to study the role of these cells and
the browning of white fat on whole-body
physiology. When Adipo-PRDM16 KO
mice were fed a chow diet, no differencewas observed in food intake or activity between the mutant
and control groups (Figures S3A and S3B). Adipo-PRDM16 KO
mice also showed no difference in O2 consumption but did
have a significantly increased respiratory exchange ratio (RER),
suggesting a decrease in utilization of fatty acid oxidation as
an energy substrate (Figures S3C and S3D). We also studied
these animals after injection with CL. Control animals showed
a significant increase in O2 consumption (6.5%–13.9%) following
each injection. KO mice showed no increase in O2 consumption,
suggesting that ablation of beige adipocyte function can affect
whole-body energy expenditure (Figure 3D).
Adipo-PRDM16 KO Mice Develop Obesity and Insulin
Resistance
Animals were then subjected to a physiological challenge in the
form of a high-fat, high-carbohydrate diet. Adipo-PRDM16 KO
mice showed no difference in body weight from control animals
on a chow diet, but demonstrated increased weight gain on a
HFD (Figures 4A and 4B). Over 7 weeks at thermoneutrality,
KOs on either a chow or HFD showed no difference in body
weight compared to controls (Figures S4A and S4B). Of note,
Ucp1 KOmice show significant weight gain over this time period
at thermoneutrality, presumably due to defects in classical
brown fat function (Feldmann et al., 2009).
Body composition analysis was done after 16 weeks on HFD,
when the weight curves had just started to diverge. Mutant
animals had significantly increased fat mass, with no change in
lean body mass (Figure 4C). These mice also showed an inter-
esting change in the distribution of fat mass: KO animals had
SubQ fat mass (inguinal depot) nearly twice that of controls,
while the VISC (epididymal) and BAT masses were unchanged
(Figure 4D). Metabolic analysis of mice after 2 weeks of HFD
showed no significant differences in food intake, activity, O2
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Figure 4. Obesity andAltered Fat Distribution
in Adipo-PRDM16 KO Mice
(A and B) Body weights of Adipo-PRDM16 KO and
control mice on standard chow (A) or HFD (B). HFD
was started at 4 weeks of age. Experiments were
done with male mice, n = 12–15 per group.
(C) Body composition of Adipo-PRDM16 KO and
control mice following 16 weeks on HFD. n = 12 for
controls and n = 19 for KOs.
(D) Weights of individual fat pads from Adipo-
PRDM16 KO and control mice following 18 weeks
on HFD. n = 11 per group.
Data are presented as mean ± SEM. *p < 0.05. See
also Figure S4.consumption, or RER compared to control animals (Figures
S4C–S4F). O2 consumption was also unchanged after longer
periods on HFD, likely reflecting the fact that indirect calorimetry
is insufficiently sensitive to detect small differences in energy
expenditure, which could result in modest obesity over a pro-
longed period (Butler and Kozak, 2010).
SubQ adipocytes in high-fat fed Adipo-PRDM16 KO mice
were markedly larger than those in control mice (Figure 5A).
Quantitative assessment confirmed a 33% increase in mean
adipocyte area in the SubQ depot of mutant animals to a size
equivalent to adipocytes in the VISC depot (Figure 5B). KO
mice had no difference in mRNA expression levels of general
markers of adipose differentiation, though they did have a trend
toward increased Glut4 mRNA levels compared to controls
(Figure S5A). The morphology and size of VISC epididymal
adipocytes was unchanged between control and KO animals
(Figure S5B). We used flow cytometry to quantitate the major
myeloid and lymphoid subsets in the adipose tissue of high-fat
fed mice. When compared to control animals, SubQ adipose
tissue from KOs had a significant increase in the fraction and
number of CD11b+F4/80+ macrophages (Figure 5C), along with
increased crown-like structures (Figure 5D). These alterations
were restricted to SubQ adipose tissue, as there were no differ-
ences in the representation of CD11b+F4/80+ macrophages in
the VISC adipose tissue or spleen from KO animals (Figure S5C).
No other immune cell subsets, including T regulatory cells, which
have been shown to play a role in metabolic disease (Cipolletta
et al., 2012), were altered in adipose tissue or lymphoid organs
from KO mice (Figure S5D).
We next assessed glucose homeostasis in Adipo-PRDM16
KO mice. We performed hyperinsulinemic-euglycemic clamps,
a sensitivemethod for assessingwhole-body and tissue-specific
insulin sensitivity. These studies were performed at a time well
before the weight curves of KO animals diverged from controls
(6 weeks on HFD). There was no difference in fasting plasmaCell 156, 304–31glucose between groups (Figure S6A).
However, fasting plasma insulin levels
were significantly increased (55%
increased, p < 0.05) in Adipo-PRDM16
KO mice, suggestive of insulin resistance
(Figure 6A). During the clamp, plasma
glucose levels were matched between
groups at approximately 120 mg/dl (Fig-ure S6A). Adipo-PRDM16 KO mice showed significant whole-
body insulin resistance as evidenced by a markedly reduced
glucose infusion rate (64% of controls) and decreased whole-
body glucose uptake (Figures S6B and 6B). Mutant mice also
demonstrated significant hepatic insulin resistance with
decreased insulin-stimulated suppression of endogenous
glucose production (53% in KOs versus 95% in controls)
(Figure 6C). This primary alteration in adipose tissue was also
associated with hepatic steatosis in KO animals (Figure 6D).
Moreover, KO animals showed a failure in insulin-mediated
suppression of lipolysis (6% in KOs versus 45% in controls)
(Figure 6E). Although control and Adipo-PRDM16 KO mice
were dosed with the same amount of insulin, clamped insulin
levels weremodestly increased in the KOs (p = 0.08, Figure S6C),
suggesting impaired insulin clearance consistent with insulin
resistance. Gene expression analysis from a separate cohort of
mice following 6 weeks HFD, showed marked reductions of
many thermogenic genes in KO SubQ adipose tissue compared
to controls. Some of these genes showed a modest, but signifi-
cant, reduction in classical BAT (Figure S6D).
A bolus of 14C-2-deoxyglucose was administered to deter-
mine tissue-specific rates of glucose transport. Marked reduc-
tions in glucose uptake were observed in the SubQ (79%
decreased) and VISC fat (53% decreased) (Figure 6F). Interest-
ingly, glucose uptake in the classical BAT was actually higher
in Adipo-PRDM16 KO mice. Skeletal muscle glucose uptake
was no different between control and KO mice. These data indi-
cate that deletion of PRDM16 in adipocytes results in selectively
dysfunctional beige adipose function with strong effects on
whole-body and tissue-specific insulin sensitivity.
Adiponectin levels showed no difference between control and
KO mice (Figure S6E). Moreover, PRDM16 null adipose cells do
not appear to have cell-autonomous defects in insulin signaling,
as levels of total and phosphorylated Akt were unchanged be-
tween control and KO primary SubQ adipocytes (Figure S6F).6, January 16, 2014 ª2014 Elsevier Inc. 309
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Figure 5. Increased Cell Size and Macrophage Accumulation in Subcutaneous Adipose Tissue from Adipo-PRDM16 KO Mice
(A and B) Cell size in inguinal SubQ adipose tissue from male Adipo-PRDM16 KO and control mice following 18 weeks on HFD. Representative images from
hematoxylin and eosin (H&E) stained sections. Images are shown at 53 magnification. Scale bar, 100 mm. (B) Mean adipocyte area from inguinal SubQ and
epididymal VISC adipose tissue. n = 3 per group.
(C) Flow cytometry quantitation of CD11b+F4/80+ macrophages in SubQ adipose tissue from Adipo-PRDM16 KO and control mice following 6 weeks on HFD.
(D) Morphological analysis for crown-like structures using Mac-2 staining from Adipo-PRDM16 KO and control mice following 6 weeks on HFD.
For (C) and (D), experiments were done with male mice 8–10 weeks old at start of HFD, n = 5–6 per group.
Data are presented as mean ± SEM. *p < 0.05. See also Figure S5.Loss of Metabolic Benefit with Transplantation of
Subcutaneous Fat from Adipo-PRDM16 KO Mice
This spectrum of phenotypes in Adipo-PRDM16 KO mice
suggested that PRDM16 might be required for the healthful
actions of SubQ adipose tissue. To address this, we trans-
planted SubQ fat pads (Gunawardana and Piston, 2012) from
weanling pups of the two PRDM16 genotypes into high fat fed
wild-type recipients and animals were then maintained on
HFD. All recipients gained weight equally following the trans-
plants. A glucose tolerance test was done at 6 weeks, and a
highly significant difference was observed between the groups,
with worse glucose tolerance in recipients of KO tissue (Fig-
ure 6G). There was no significant difference in insulin tolerance
between these groups. This result has been replicated in a sepa-
rate cohort of transplant recipients. The inclusion of a donor
group from PRDM16 overexpressing, transgenic mice showed
that glucose tolerance appears to track with PRDM16 levels in
donor tissue (Figure S6G).
SubQ Adipose Tissue of Adipo-PRDM16 KO Mice
Acquires a Partial VISC Adipose Phenotype
The combination of adipose and hepatic insulin resistance and
the presence of larger adipocytes in KO SubQ adipose tissue310 Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc.with increased macrophage accumulation suggested a pheno-
type more typical of VISC obesity. These observations indicated
that Adipo-PRDM16 KO SubQ adipose tissue might have
developed some of the deleterious characteristics of VISC adi-
pose tissue. To address this in an unbiased fashion, we used
whole-genome microarrays to define depot-specific gene
expression and then examined whether this molecular profile
appeared ‘‘visceralized’’ in the SubQ adipose tissue of Adipo-
PRDM16 KO animals.
Depot-enriched gene expression was studied by comparing
RNA expression in adipose tissue from two SubQ depots
(inguinal and axillary) to that from two VISC depots (epididymal
and mesenteric). We defined a VISC gene set as containing
genes with >3-fold increased expression and a p value < 0.05
between the VISC and SubQ depots. Sixty genes met these
criteria. We then determined which of these genes had expres-
sion that was enriched >2-fold in fractionated adipocytes from
VISC versus SubQ adipose tissue, to avoid studying differences
due to other cell types. Twenty-six out of 60 genes met this
requirement. We then studied the expression of these 26
visceral-selective genes in SubQ adipose tissue from control or
Adipo-PRDM16 KO mice fed a HFD. 11/26 were >2-fold
increased with p value < 0.05 in KOs versus controls. We then
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Figure 6. Insulin Resistance, Hepatic Steatosis, and Altered Glucose Uptake in Adipo-PRDM16 KO Mice
(A–E) Hyperinsulinemic-euglycemic clamp studies on Adipo-PRDM16 KO and control mice after 6 weeks on HFD.
(A) Fasting insulin levels.
(B) Glucose infusion rate and whole-body glucose uptake.
(C) Basal and insulin-stimulated endogenous glucose production.
(D) Liver triglyceride content.
(E) Basal and insulin-stimulated levels of nonesterified fatty acids.
(F) 2-deoxyglucose uptake in tissues from Adipo-PRDM16 KO and control mice.
Data are presented as mean ± SEM. *p < 0.05, # p = 0.09. Clamp studies were done with male mice, 8 weeks old at the start of HFD. n = 7–8 per group.
(G) Intraperitoneal glucose tolerance test (1.5 mg/kg) in male, high-fat-fed recipients of Adipo-PRDM16 KO or control SubQ adipose tissue. The GTT was done
6 weeks following transplantation. n = 6 per group. *p < 0.05 by ANOVA.
Data are presented as mean ± SEM. See also Figure S6.selected 30 genes at random that were expressed in SubQ
adipocytes and used these as a comparator. Only 1/30 was
>2-fold increased with a p value < 0.05 in KO versus control
adipose tissue.
These data are shown as a heat map with the color indicating
the fold-change for each gene of this VISC fat gene expression
set in SubQ adipose tissue from 11 KO mice relative to that
of the control group (Figure 7A). The acquisition of a VISC-
selective expression profile is highly significant (11/26 versus
1/30 genes, p = 0.0004 by chi-square). In addition this VISC
profile contains a number of proinflammatory genes of known
functional importance: Serum amyloid A3 (Saa3), Angiotensino-
gen (Agt), 12/15 lipoxygenase (Alox15), Osteoprotegerin
(Opgn), and Retinaldehyde dehydrogenase 2 (Raldh2) (Fig-
ure 7B). The VISC-selective expression profile also includes
three transcription factors (Tcf21, Bnc1, and Wt1) (Figure 7C).
Two of these proinflammatory genes (Agt and Raldh2) were
further increased in VISC adipose tissue from KO mice,
compared to controls, though the expression of the three
VISC-enriched transcription factors was unchanged (Figures
S7A and S7B). Of note, more than half of these proinflamma-
tory genes and transcription factors were significantly up-
regulated in PRDM16 KO SubQ fat cells differentiated in vitro
(Figures S7C and S7D). This strongly suggests that the altered
molecular profile in PRDM16 null adipose tissue is not simply a
consequence of the metabolic dysregulation seen in these
animals.High-fat feeding also resulted in significantly decreased
expression of typical thermogenic genes in SubQ adipose tissue
of Adipo-PRDM16 KOs (Figure 7D), suggesting a coordinated
balance between the molecular phenotype of VISC and SubQ
adipose tissue. We considered whether PRDM16might normally
induce thermogenesis and repress inflammation, while a VISC-
selective transcription factor might induce inflammation and
repress thermogenesis. The three transcription factors identified
in our VISC-enriched profile (shown above) were immediate
candidates for conferring these depot-specific properties. We
focused on Wt1 because it showed cell-autonomous induction
in the absence of PRDM16 (Figure S7D) and is strikingly enriched
in VISC adipose tissues (Figure 7E).
We obtained Wt1lox/lox mice (Gao et al., 2006) and crossed
them to Adiponectin-cre mice. We isolated adipose tissue SVF
from Wt1lox/lox;cre+ (KO) and Wt1lox/lox;cre- (control) VISC fat and
differentiated them in vitro. We detected a significant reduction
in the native Wt1 transcript and a corresponding increase in a
deleted transcript in KO cells compared to controls (Figure 7F).
Both control and KO cells differentiated equally, with nomorpho-
logical differences. There were small but significant differences
in markers of adipocyte differentiation. Importantly, deletion of
Wt1 resulted in a striking induction of thermogenic genes (5.6-
fold for Cidea, 6.1-fold for Prdm16, and 24.7-fold for Ucp1)
and repression of several proinflammatory genes (46% for
Saa3 and 30% for Agt) compared to controls (Figure 7G). These
data strongly suggest that reciprocal regulation of PRDM16 andCell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc. 311
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Figure 7. Induction of a Visceral Adipose Tissue Gene Expression Profile in Adipo-PRDM16 KO Subcutaneous Adipose Tissue
(A) Heat map showing relative expression of VISC-selective and randomly selected genes in SubQ adipose tissue from Adipo-PRDM16 KO mice after 18 weeks
on HFD. Each row depicts an individual gene. Each column depicts the expression in a KO sample relative to the average expression in control mice. Average fold
change is indicated in the column to the right. Fold change for each individual sample is color-coded according to the key.
(B and C) Normalized expression of proinflammatory genes (B) and transcription factors (C).
(D) Normalized expression of thermogenic genes.
For (A)–(D), gene expression was measured in male mice following 18 weeks HFD. n = 11 per group.
(legend continued on next page)
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Wt1 is at least partly responsible for determining whether adi-
pose expresses a SubQ or VISC gene program. Interestingly,
in a differentiation time course in primary adipocytes from
Adipo-PRDM16 KO mice, successive reduction in Prdm16
mRNA levels is closely associated with progressive increases
in Wt1 mRNA levels (Figure S7E).
DISCUSSION
We have described here a mouse model with specific ablation
of beige adipocyte function. Adipo-PRDM16 KO mice have
significant reductions in thermogenic gene expression and O2
consumption of white adipose tissue, both in the basal state
and following stimulation with cold and the b3-adrenergic
agonist CL. On the other hand, both thermogenic gene expres-
sion and O2 consumption in classical BAT appears unaffected
by PRDM16 deletion. Importantly, the direct measure of tissue-
specific glucose uptake during hyperinsulinemic-euglyemic
clamps indicated that there is essentially no functional deficiency
in classical BAT. In fact, glucose uptake was elevated in KOBAT,
suggesting this tissue might be compensating for the absence of
functional beige adipose cells. Thismay represent amirror image
of the recent report of hyperactive beige adipose tissue in the
setting of dysfunctional classical brown fat (Schulz et al.,
2013). While deletion of PGC1a in adipocytes also leads to
impaired thermogenic function in SubQ adipose tissue and
metabolic defects (Kleiner et al., 2012; Pardo et al., 2011), the
magnitude of the defect appears far greater in the Adipo-
PRDM16 KO mice. Pgc1a expression is reduced in our KOs,
consistent with PRDM16 being upstream of PGC1a (Seale
et al., 2007).
The physiological relevance of beige fat has been questioned
since expression of Ucp1 mRNA and protein is at least an order
of magnitude lower in these cells than in classical BAT (Neder-
gaard and Cannon, 2013). While mice with more beige fat cells
have shown a protection from metabolic diseases (Seale et al.,
2011; Vegiopoulos et al., 2010), the functional role of this cell
type when present in normal amounts has not been clear. As
shown here, animals deficient in competent beige adipocytes
develop late-onset obesity on HFD. This is associated with
increased fat mass, including a striking increase in SubQ adi-
pose stores. While we were unable to detect differences in
whole-body O2 consumption in the basal state, KO animals
showed significantly reduced energy expenditure following
treatment with a b3-adrenergic agonist.
Hyperinsulinemic-euglycemic clamp studies on beige cell-
deficient animals before the development of obesity showed
significant insulin resistance, specifically affecting white adi-
pose tissues and liver. Along with this, mutant animals devel-
oped hyperinsulinemia and hepatic steatosis. This model of
insulin resistance is unusual in that glucose uptake in skeletal
muscle seems unaffected. Beige adipocytes may have as
yet undescribed actions on other tissues, with recent studies(E) qPCR analysis ofWt1mRNA frommultiple adipose tissues from 8- to 10-week
adipose tissue. n = 9 per group.
(F and G) Normalized expression of Wt1 (F) and thermogenic and proinflammato
Data are presented as mean ± SEM. *p < 0.05, #, p = 0.058. See also Figure S7.suggesting they regulate bone metabolism (Rahman et al.,
2013).
This mouse model of beige fat deficiency differs in some inter-
esting ways from mouse models with specific loss of classical
BAT function. Mice with defective BAT develop obesity and insu-
lin resistance (Feldmann et al., 2009; Hamann et al., 1996; Tseng
et al., 2008). However, such animals tend to have defects in
maintaining core temperature. When our KO mice were placed
at 4C, they showed no alteration in body temperature.
In the absence of PRDM16, mice developed marked enlarge-
ment of the SubQ adipose tissue. Interestingly, domestic pigs,
which have abundant SubQ adipose tissue, lack functional
UCP1 (Trayhurn et al., 1989). Similarly, Adipo-PRDM16 KO
mice have virtually no UCP1 in their SubQ adipocytes. Histolog-
ical examination of the SubQ fat from these mice demonstrated
the presence of larger, unilocular cells, which become equivalent
in size to VISC fat cells. KO mice also showed a virtual absence
of small, multilocular UCP1+ adipocytes. PRDM16-deficient
animals not only lose the thermogenic program characteristic
of beige adipocytes, but additionally, the SubQ adipose tissue
acquires some of the deleterious characteristics of VISC fat,
including the accumulation of macrophages. It is not yet clear
whether acquisition of this VISC phenotype is causally related
to loss of the thermogenic function of beige adipocytes or
reflects a separate function of PRDM16 in adipocytes. The phys-
iological significance of this change in depot phenotype, how-
ever, is made clear by our fat transplantation studies. Animals
that received PRDM16-deficient SubQ pads had significantly
worse glucose tolerance than recipients of control fat pads,
recapitulating experimental animal models with increased VISC
fat (Masuzaki et al., 2001).
Since reduced thermogenesis in SubQ adipose tissue of
Adipo-PRDM16 KO mice is coupled to increased inflammatory
gene expression and macrophage accumulation, it is not
possible to disentangle the relative contribution of each of these
alterations to the overall phenotype. Our data suggest that
PRDM16 specifically affects the function of beige fat cells in
the SubQ depots and that this is the proximal defect, occurring
prior to acquisition of VISC properties upon high-fat feeding.
Additionally, a recent paper showed that PRDM16 is only de-
tected in multilocular and paucilocular cells within the omental
fat of humans with pheochromocytoma (Frontini et al., 2013),
consistent with its enrichment and selective expression in beige
adipocytes. However, we cannot exclude possible effects from a
very small amount of PRDM16 in true white adipocytes.
A comprehensive molecular analysis showed significant
expression of a VISC gene signature in the SubQ fat of
PRDM16 KO mice. This signature was developed based on
objective criteria, using multiple depots of each type, and
employing fat cell purification to avoid confounding by other
cell types. These data clearly suggest that deletion of PRDM16
and ablation of beige adipocytes not only affects thermogenesis,
but also results in substantial ‘‘visceralization’’ of the SubQ-old, male wild-type mice, normalized to mRNA expression in epididymal white
ry genes (G) in primary VISC Wt1lox/lox;cre+ adipocytes. n = 6 per group.
Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc. 313
adipose tissue. This analysis establishes with statistical signifi-
cance (p = 0.0004) that deletion of PRDM16 results in acquisition
of at least some aspects of the molecular phenotype of VISC
adipose tissue. Of note, several of these VISC markers ex-
pressed in KO SubQ pads are of interest in metabolic diseases:
Agt (Kalupahana et al., 2012), SAA3 (Kwon et al., 2012), Alox15
(Nunemaker et al., 2008; Sears et al., 2009), Opgn (Skopkova´
et al., 2007), and Raldh2 (Frey and Vogel, 2011).
Three transcription factors (WT1, TCF21, and BNC1) were
among the visceral signature genes induced in Adipo-PRDM16
KO SubQ adipose tissue. WT1 and TCF21 have known roles in
urogenital development, and KO models of these genes have
similar phenotypes (Kreidberg et al., 1993; Quaggin et al., 1999),
suggesting that WT1 and TCF21 may function in the same
pathway. WT1 is also a known tumor suppressor, which is
mutated inWilms’ tumor (Haber et al., 1990). A role forWT1 in ad-
iposebiology has not previously been reported. Deletion ofWt1 in
primary VISC adipocytes resulted in downregulation of genes in
the VISC signature and upregulation of thermogenic genes char-
acteristic of SubQ/beige adipocytes. These data suggest an
epistatic relationship between a thermogenic program regulated
by PRDM16 and a VISC-specific program regulated byWT1. This
appearsanalogous to the regulationof thermogenesisversus lipid
storage by PRDM16 and TLE3 (Villanueva et al., 2013).
Thus, it is now clear that beige fat cells make an important
contribution to whole-body physiology of mice. In the absence
of functional beige fat, mice are prone to obesity, insulin resis-
tance, and hepatic steatosis when challenged with HFD. In light
of the presence of beige fat cells in normal adult humans (Lidell
et al., 2013; Sharp et al., 2012; Wu et al., 2012), these cells are
an attractive target for the treatment of obesity and type 2
diabetes. This influence of beige fat on liver metabolism is partic-
ularly interesting since there has been much more attention
recently to the frequency and importance of hepatic steatosis
as an important comorbidity in the metabolic syndrome (Angulo,
2002). Identification of pharmacological activators of PRDM16
targeted to beige adipocytes could hold promise as a new class
of therapeutics.
EXPERIMENTAL PROCEDURES
Animals
Animal experiments were performed according to procedures approved by
the Dana-Farber Cancer Institute and Yale University School of Medicine
IACUC. The generation of Adipo-PRDM16 KO mice and the other mouse
strains used is described in the Extended Experimental Procedures.
Molecular Studies
qPCR and western blotting were done according to standard methods. Anti-
bodies used were PRDM16 (sheep anti-PRDM16, R&D), PPARg (Cell
Signaling), TBP (Santa Cruz), AKT and P-AKT (Cell Signaling), and Actin (Cell
Signaling). Microarray hybridization and scanning were performed by the
Dana-Farber Cancer Institute microarray core facility using Affymetrix Mouse
Genome 430A 2.0 Gene Chip arrays. The GEO accession number for microar-
ray data reported in this paper is GSE53307.
Histological Analysis
Tissues were fixed in 4% paraformaldehyde. Paraffin embedding and
sectioning were done by the Dana-Faber/Harvard Cancer Center Research
Pathology core facility. Adipocyte size was calculated as described (Vitali314 Cell 156, 304–316, January 16, 2014 ª2014 Elsevier Inc.et al., 2012). The mean area of 200 random adipocytes (100 per section)
from each animal was calculated using the Nikon LUCIA image program
(version 4.61; Laboratory Imaging).
Immunohistochemistry
Immunohistochemistry was performed as previously described (Giordano
et al., 2013) and as in the Extended Experimental Procedures.
Respiration
Tissue respiration was performed using a Clark electrode (Strathkelvin Instru-
ments). Freshly isolated tissues were isolated from untreated mice or after five
daily injections of 1.0 mg/kg CL (Sigma). Tissues were minced and placed in
respiration buffer. For each adipose depot, readings were taken with three
separate pieces of tissue of equivalent size. O2 consumption was normalized
to tissue weight. For assays on cultured cells, fully differentiated adipocytes
were trypsinized and a single-cell suspension was placed in respiration buffer.
Total respiration was measured and then oliogmycin was added to measure
uncoupled respiration.
Flow Cytometry
Epididymal VISC and inguinal SubQ adipose tissue and spleen were excised
and digested for 20 min with collagenase type II (Sigma). Cell suspensions
were filtered through a 40 mm sieve, and the SVF was collected after centrifu-
gation at 450 g for 10min. For T cell analysis, cells were stained with anti-CD45
(clone 30-F11), -CD3 (145-2C11), -CD4 (GK1.5), -CD8 (5H10), and -CD25
(PC61) (BioLegend) and were fixed, permeabilized, and intracellularly stained
for Foxp3 (FJK-16 s) and GATA3 (TWAJ) (eBiosciences). For myeloid cell anal-
ysis, cells were stained with anti-CD45, -CD3 (145-2C11), -CD11b (M1/70),
-CD11c (N418), F4/80 (CI:A3-1), and anti-Ly6c (HK1.4) (BioLegend). B cells
were stained with anti-CD45, and anti-CD19 (6D5) (BioLegend). Cells were
analyzed using an LSRII instrument (BD Bioscience) and FlowJo software.
Metabolic Phenotyping
Metabolic phenotyping and hyperinsulinemic-euglycemic clamps were per-
formed as described (Jurczak et al., 2012; Ye et al., 2012) and as in the
Extended Experimental Procedures. All experiments were done with male
mice, with the exception of the CL gene expression and tissue respiration
studies. Energy expenditure was analyzed using a Comprehensive Lab Animal
Monitoring System (Columbus Instruments). Fat and lean mass wasmeasured
by MRI. Cold exposure and thermoneutrality experiments were done at either
4C or 30C. Total adiponectin levels were measured by ELISA (Millipore).
Fat Transplant Studies
Inguinal SubQ adipose tissue was removed from 2- to 3-week-old Adipo-
PRDM16 KO, littermate control mice, or aP2-PRDM16 transgenic mice
(donors) and transplanted into the SubQ space of C57Bl6 mice (recipients)
that had been on HFD for 6 weeks. Transplants were performed as described
(Gunawardana and Piston, 2012). Glucose tolerance tests were done 6 weeks
posttransplant. Animals were fasted for 4 hr and then received intraperitoneal
glucose (1.5 mg/kg). Insulin tolerance tests were done 8weeks posttransplant.
Animals were fasted for 4 hr and then received intraperitoneal Humulin R insu-
lin (1.0 U/kg, Lilly).
Cell Culture
For primary adipocytes, SVF from inguinal or epididymal fat from 5- to 6-week-
old mice was prepared and differentiated for 6–8 days as described (Kajimura
et al., 2009). Where indicated, cells were treated with isoproterenol 10 mM for
6 hr (Sigma) or FGF21 100 ng/ml overnight (R&D).
Statistics
The Student’s t test was used for single comparisons. Two-way ANOVA with
repeated-measures was used for the GTT studies. Chi-square was used
to compare the VISC-selective gene set to a randomly selected set of genes.
Unless specified, an asterisk (*) indicates p < 0.05.
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